Investments Development Version
Logo
Company Name
Shares, Investment, Holdings
Website
Listed equity shares

A holding of 620,581 shares representing a 0.63% equity interest

A holding of 595,902 shares representing a 1.36% equity interest

A holding of 1,307,692 shares representing a 0.31% equity interest

A holding of 250,000 shares representing a 0.28% equity interest

A holding of 1,676,135 shares representing a 2.23% equity interest

A holding of 675,676 shares representing a 0.76% equity interest

A holding of 341,666 shares representing a 4.92% equity interest

A holding of 1,200,000 shares representing a 0.33% equity interest

A holding of 23,928,080 shares representing a 28.82% equity interest

A holding of 6,000,000 shares representing a 5.07% equity interest
Unlisted equity shares

A holding of 71,429 shares representing a 1.30% equity interest

A holding of 145,833 shares representing a 1.03% equity interest
Other equity interests

8% economic interest in the Covid-19/diabetes drug AZD1656, which is in the course of development and commercialisation by St George Street Capital Limited